Anifare Pharma Private Limited
About Anifare Pharma Private Limited
Data last updated:
Anifare Pharma Private Limited is a private limited company based in Raiganj, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24290WB2019PTC235599. Its GSTIN is 19AATCA1174D1ZL (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bankim Chakraborty and Somak Sankar Mukherjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Bankim Chakraborty S/O Barun Kumardanghi, Raiganj, West Bengal, India – 733134.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.16 Lakh, a growth of 22% compared to the previous year. Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
Company details
Contact details
Anifare Pharma Private Limited's registered office is in Raiganj, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Bankim Chakraborty S/O Barun Kumardanghi, Raiganj, West Bengal, India – 733134
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Anifare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anifare Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Anifare Pharma Private Limited, buy the company report.
Financials of Anifare Pharma Private Limited
FY 2025 filings availableAnifare Pharma Private Limited reported revenue of ₹2.16 Lakh (up 22% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 22% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 21%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anifare Pharma Private Limited, buy the company report.
Board of directors of Anifare Pharma Private Limited
Anifare Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bankim Chakraborty | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
| Somak Sankar Mukherjee | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
Peer comparison
Anifare Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| L.D.S. Retails Private Limited | ₹2.16 Lakh (FY 2018) | -78.0% | Etawah, Uttar Pradesh, India | |||
| Kuber Food Products India Private Limited | ₹2.16 Lakh (FY 2025) | -1.0% | New Delhi, Delhi, India | |||
| Medpoint Pharmaceuticals Private Limited | ₹2.16 Lakh (FY 2023) | Kanchrapara, West Bengal, India | ||||
| Om Shree Dealers Private Limited | ₹2.16 Lakh (FY 2017) | 20.0% | Kolkata, West Bengal, India | |||
| Anifare Pharma Private Limitedthis company | ₹2.16 Lakh (FY 2024) | 22.0% | Raiganj, West Bengal, India | |||
| Aciem Avart Electec Private Limited | ₹2.16 Lakh (FY 2018) | 10.0% | New Delhi, Delhi, India | |||
| Didis Online Private Limited | ₹2.16 Lakh (FY 2024) | 396.0% | Vapi, Gujarat, India | |||
| Asterales Lifesciences Private Limited | ₹2.16 Lakh (FY 2021) | Bangalore, Karnataka, India | ||||
| Dicollare Suitings Private Limited | ₹2.16 Lakh (FY 2020) | Delhi, India | ||||
| Minshi Creation Private Limited | ₹2.16 Lakh (FY 2023) | 53306.0% | Delhi, India | |||
| Hills Solar Power Solutions (OPC) Private Limited | ₹2.15 Lakh (FY 2022) | Hamren, Assam, India |
To see the full peer comparison of Anifare Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anifare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anifare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anifare Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AATCA1174D1ZL | West Bengal | Active | 12 Sep 2020 |
To see the full GST registrations and return filing status of Anifare Pharma Private Limited, buy the company report.
Recent activity
Anifare Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Bankim Chakraborty was appointed as Director on 31 Dec 2019.
Frequently asked questions
Anifare Pharma is an active private limited company based in Raiganj, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U24290WB2019PTC235599.
Anifare Pharma has 2 current directors:
- Bankim Chakraborty - Director
- Somak Sankar Mukherjee - Director
The latest financial statements of Anifare Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Anifare Pharma is 19AATCA1174D1ZL, registered in West Bengal.
The CIN (Corporate Identification Number) of Anifare Pharma is U24290WB2019PTC235599. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anifare Pharma was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Anifare Pharma by revenue are L.D.S. Retails Private Limited, Kuber Food Products India Private Limited, Medpoint Pharmaceuticals Private Limited, Om Shree Dealers Private Limited, Aciem Avart Electec Private Limited and 5 more, all in the same principal business activity (retail trading).
Bankim Chakraborty was appointed as Director on 31 Dec 2019. Somak Sankar Mukherjee was appointed as Director on 31 Dec 2019.
The registered office of Anifare Pharma is at CO Bankim Chakraborty SO Barun Kumardanghi, Raiganj, West Bengal, India – 733134.
Anifare Pharma operates in the chemicals industry, in the manufacturing segment.
Anifare Pharma can be reached at its registered office: CO Bankim Chakraborty SO Barun Kumardanghi, Raiganj, West Bengal, India – 733134.